LAUSANNE, Switzerland (AP) — LAUSANNE, Switzerland (AP) — AC Immune SA (ACIU) on Friday reported a loss of $18 million in its fourth quarter.
The Lausanne, Switzerland-based company said it had a loss of 18 cents per share.
The biopharmaceutical company posted revenue of $423,000 in the period.
For the year, the company reported that its loss widened to $85 million, or 84 cents per share. Revenue was reported as $4.3 million.
The company's shares closed at $3. A year ago, they were trading at $2.32.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ACIU at https://www.zacks.com/ap/ACIU
/Nvidia%20logo%20and%20sign%20on%20headquarters%20by%20Michael%20Vi%20via%20Shutterstock.jpg)
/Goldman%20Sachs%20Group%2C%20Inc_%20logo%20sign-by%20Poetra_RH%20via%20Shutterstock.jpg)
/A%20SoFi%20logo%20on%20an%20office%20building%20by%20Tada%20Images%20via%20Shutterstock.jpg)
/AI%20(artificial%20intelligence)/3D%20Graphics%20Concept%20Big%20Data%20Center%20by%20Gorodenkoff%20via%20Shutterstock.jpg)